AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06219447 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VRRS Home Tablet or Medico Amico Kids APP
Description: Tele-rehabilitation (TR) permits intensive and personalized intervention monitored by clinicians in an ecological friendly, home setting. The VRRS Home Kit, comprising a tablet and peripheral devices, permits TR of cognitive, speech and motor functions. These peripherals such as sensors and balances allow motor rehabilitation across different body districts involved (upper and lower limbs, trunk). Touch screen activities, enables neuropsychological and speech therapy sessions. Medico Amico APP, offers a wide library of cognitive, language and motor exercises, stratified by difficulty levels, targeting specific functions. An avatar guides real-time movements, offering visual references. Adjustable parameters include duration, repetitions, difficulty, speed, movement amplitude. Both technologies facilitate TR sessions via a dedicated platform, that can occur in real-time, involving interaction with patients, or independently with continuous monitoring by clinical staff.
Study NCT05229120 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking
Description: The adapted episodic future thinking (EFT) intervention will focus on generation of vivid, substance-free, rewarding events that could happen in the future with their children.
Study NCT05864300 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neurocheck frequency
Description: Randomized to hourly or every-other-hour examinations
Study NCT06245291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imdusiran
Description: subcutaneous injection
Study NCT06245291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: intravenous injection
Study NCT05977452 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Michigan Risk Score, Caprini Risk Assessment Model , Maneval scale
Description: Patients with PICC placement will be assessed by the Michigan Risk Score, Caprini Risk Assessment Model , Maneval scale（Chinese version） to predict the risk of PICC-related thrombosis. The time of evaluation are the day during PICC placement, 24-48h after PICC placement, and every time when patients receive PICC maintenance.
Study NCT05197582 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: tele-monitoring
Description: The symptoms of the patients were evaluated by calling the patients on the 1st, 5th, and 9th days of the quarantine by the researchers.
Study NCT05968755 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: A chatbot designed to promote PrEP awareness and uptake for Black MSM
Description: Participants in the intervention group will have access to a theory-informed (Self-Determination Theory) chatbot and receive an automated personalized question message (root-node message) from the chatbot. The root-node messages are questions written into the chatbot algorithms to initiate interactive communication with participants. In each round of the interactive communication, the chatbot will provide automated personalized PrEP-related information, autonomous motivation, and psychological needs based on Self-Determination Theory constructs.
Study NCT05968755 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: General educational messages
Description: Participants in the control group will received general education messages from a research assistant including healthy diet, exercise, and COVID-19 prevention. The frequency of contact will be pre-specified by participants in interviews prior to the RCT.
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRF membrane tamponade surgery in macular hole
Description: A specially formulated PRF membrane, as described previously, was filled into the macular hole to promote fissure repair.
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ILM peeling in macular hole
Description: The treatment of the macular hole was ILM peeling.
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRF membrane grafting in pterygium
Description: Used of autologous PRF membrane to cover the exposed conjunctiva after pterygium excision.
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Autologous conjunctival transplantation in pterygium
Description: Used of autologous conjunctiva to cover exposed sclera after pterygium excision
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: autologous PRF membrane grafting in trabeculectomy for glaucoma
Description: Used of autologous PRF membranes to cover the exposed sclera after trabeculectomy for glaucoma.
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Amniotic membrane in trabeculectomy for glaucoma
Description: Used of amniotic to cover the exposed sclera after trabeculectomy for glaucoma.
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRF membrane grafting incorneal ulcer
Description: After surgical debridement of corneal ulcers, autologous PRF membrane was placed over the corneal wound to promote corneal healing
Study NCT06228846 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YY001
Description: Oral
Study NCT05559125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1002 Injection
Description: Intravenous injection
Study NCT05559125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1005 Injection
Description: Intravenous injection
Study NCT06480552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TEV-56278
Description: Administered intravenously
Study NCT06200727 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Amniotic membrane in corneal ulcer
Description: After surgical debridement of corneal ulcers, autologous amniotic membrane was placed over the corneal wound to promote corneal healing
Study NCT06293885 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose 50
Description: a solution of 50% glucose (D50) will be injected into your pleural space
Study NCT06293885 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care - No Dextrose 50
Description: Standard of Care
Study NCT06521359 — intervention group
Intervention type: DEVICE
Intervention: flow cytometry
Description: Two ml of peripheral venous blood samples will be collected in heparinized tubes from patients and controls for assessment of levels of TFH and TFReg cells by flow cytometry.
Study NCT05757661 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Focal Vibration
Description: A single 30-minute focal vibration procedure will be performed on both quadriceps with the V-Plus Wintecare® machine.~Three channels will be used on the muscle bellies of the rectus anterior, vastus internus and vastus externus. The positioning of the vibration heads will be done with straps designed by the manufacturer to keep the vibration focus stable on the muscle belly.~The configuration of the vibration program will be in an automatic mode of 10 seconds of vibration and 3 seconds of rest to avoid the coupling of the mechanoreceptors. The frequency used will be between 60 Hz to 150 Hz with a power of 80%.
Study NCT05757661 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Group
Description: The same procedure of the intervention group will be performed but without the focal vibration head contacting the skin (sham). A sufficient space will be left between the head and the headgear so that the vibration does not touch the skin.
Study NCT05985850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aurora 1:1 Drops (Indica)
Description: Aurora 1:1 Drops (Indica) is created by extracting cannabinoids and terpenes and the concentrated extract is then diluted in medium-chain triglyceride (MCT) oil for optimal use.
Study NCT05985850 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Medium-chain triglyceride (MCT) oil with the same appearance, color, and taste as the Aurora 1:1 Drops (Indica).
Study NCT06480552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered intravenously
Study NCT06067269 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multiparametric Magnetic Resonance Imaging
Description: Undergo multiparametric MRI
Study NCT06067269 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PSMA-PET/CT
Study NCT06067269 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04735432 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: efgartigimod PH20 SC
Description: Subcutaneous injection with efgartigimod PH20 SC
Study NCT04735432 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: efgartigimod IV
Description: Intravenous infusion of efgartigimod
Study NCT06110091 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated Behavioral Therapy Program
Description: Integrated Behavioral Therapy is a behavioral program that includes education, lifestyle habits management, cognitive, relaxation, and behavioral conditioning for nocturia and insomnia
Study NCT05545566 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thoracic ultrasound versus chest X-ray
Description: Perform un ultrasound test, in addition to Chest X-Ray (usual practice), few hours after the surgery (D0), the next day (D1) and 4 to 6 hours after drain removal.~The data are collected in the standardized protocol for the two type of imaging.~The thoracic ultrasound and the Chest X-Ray are performed, blindly each other, in the same position for the patient and the same suction level of drain.
Study NCT06530342 — intervention group
Intervention type: OTHER
Intervention: The same evaluation methods were used for both groups.
Description: No treatment applied to participants and same evaluation methods used in all athletes.
Study NCT06110091 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health Education Program
Description: Health Education Program modules focus on brain health and includes topics such physical activity, social engagement, sleep topics (e.g., changes in sleep that occur with aging, effects of poor sleep on health), medications/medical conditions, vision and hearing impairment.
Study NCT04819087 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires and Rehabilitation Programs
Description: Questionnaires and Rehabilitation Programs
Study NCT04959812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: Subjects will receive Sufentanil while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.
Study NCT04959812 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will receive a placebo pill while the effects of this placebo on tolerance to a hemorrhagic insult will be assessed.
Study NCT05302362 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation using YMS-201B(YBrain, Daejeon, Korea)
Study NCT05302362 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation using YMS-201B(YBrain, Daejeon, Korea)
Study NCT05302362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation using YMS-201B(YBrain, Daejeon, Korea)
Study NCT06406829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: The 200ug dexmedetomidine will be diluted into a 50ml syringe and administered with 0.4ug/kg/h intraoperatively and 0.05 μg/kg/h for 48 hours after surgery.
Study NCT05506839 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intervention (videoconferencing)
Description: 1 hour videoconferencing sessions over 8 weeks with an English language learner partner.
Study NCT06406829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Normal saline
Description: In the placebo group, the 0.9% saline is administered with the same volume at the same speed as the dexmedetomidine group
Study NCT06406829 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: In the placebo group, the 0.9% saline is administered with the same volume at the same speed as the dexmedetomidine group
Study NCT06406829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Local analgesic techniques
Description: The 10ml 1% ropivacaine will be diluted into a 20ml syringe . As for scalp nerve block, each nerve will be blocked separately with 1-2 mL 0.5% ropivacaine.
Study NCT06406829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: no Local analgesic techniques
Description: No Local analgesic techniques will be given.
Study NCT06406829 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: no Local analgesic techniques
Description: No Local analgesic techniques will be given.
Study NCT05577585 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine 50 MG/ML
Description: See also Arm description
Study NCT05577585 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Midazolam
Description: See also Arm description
Study NCT05577585 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine 50 MG/ML
Description: Open Label Follow Up (up to 8 Infusions)
Study NCT05107583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Pre-Exercise Meal
Description: Sixty minutes of cycling at 60% VO2peak will take place on a stationary bicycle ergometer at 16:00, after having consumed a low-carbohydrate lunch meal (\<10% carbohydrate; 35% estimated energy requirements) 2.5 hours prior.
Study NCT05107583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Carbohydrate Pre-Exercise Meal
Description: Sixty minutes of cycling at 60% VO2peak will take place on a stationary bicycle ergometer at 16:00, after having consumed a high-carbohydrate lunch meal (\~2.2 g/kg carbohydrate; 35% estimated energy requirements) 2.5 hours prior.
Study NCT05107583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasted Exercise
Description: Sixty minutes of cycling at 60% VO2peak will take place on a stationary bicycle ergometer at 16:00, after having skipped lunch, and having consumed nothing other than plain water since breakfast (08:00; 25% estimated energy requirements). Exercise will therefore commence after an 8 hour period of fasting.
Study NCT05901324 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiotherapy (IMRT)
Description: 1.8 Gy of 4-6 MV X-ray to a total dose of 23.4 Gy (13 fractions) will be delivered.
Study NCT06280534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test drug XT1061 capsules and placebo,Single dose group
Description: Eight people took capsules of the test drug XT1061 and two people took a placebo.
Study NCT06280534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test drug XT1061 capsules and placebo，Multiple dosing group
Description: D1-D7 were administered under fasting conditions for 7 consecutive days, of which D1-D6 were administered BID and D7 was administered once in the morning under fasting conditions only.Eight people took capsules of the test drug XT1061 and two people took a placebo.
Study NCT06280534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test drug XT1061 capsules and placebo，Food Impact Group
Description: Eight people in group A took the test drug XT1061 capsules and two people took placebo, and all eight people in group B took the test drug XT1061 capsules.
Study NCT06421272 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: APP-based emotion recognition intervention
Description: ASD children were asked to play emotion recognition-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.
Study NCT06421272 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: APP-based memory intervention
Description: ASD children were asked to play memory-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.
Study NCT05400629 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training program
Description: 12-week strength training program of the lower limbs consisting of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. All exercises will be perform between 6 and 8 maximal repetitions.
Study NCT05700253 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cooled Radiofrequency Ablation
Description: Image-guided genicular nerve ablation will be performed with the Coolief System (COOLIEF\* CRFA; Avanos Medical).
Study NCT05700253 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic Acid Injection
Description: Synvisc-One (\[Hylan G-F 20\]; Sanofi) will be administered as a single intra-articular dose (6 mL).
Study NCT04880642 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C21
Description: C21
Study NCT05485493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-Based Solution Focused Short-Term Group Counseling
Description: Sessions will be held online once a week, with an average duration of 60-90 minutes, in the form of 6 sessions, via video-conference applications.
Study NCT05485493 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: healthy nutrition education
Description: 60-minute single session healthy eating training
Study NCT05295706 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counterfactual Intervention
Description: The intervention occurs during the third study visit. This is a counterfactual intervention, which will involve asking the subjects to think of an alternative reality that might have been based on the concurrency of their glucose readings and the meals they ate.
Study NCT04880642 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05117580 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: telemedicine lifestyle guidance
Description: Telemedicine lifestyle advices are given during 3 months, based on telemonitoring system data.
Study NCT05585021 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Wonderlab Kids instant probiotics
Description: During study intervention, subjects are required to take the randomly assigned product based on the randomization list.~Taking assigned product directly or mix it with milk/water/other liquids below 37 ℃, take it half an hour after meal.1 bottle a day. Lasting for 24 weeks intervention period.
Study NCT05585021 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Instant probiotic placebo
Description: Subjects are required to take the randomly assigned Instant probiotic placebo based on the randomization list.~Taking assigned product directly or mix it with milk/water/other liquids below 37 ℃, half an hour after meal.~1 bottle a day. Lasting for 24 weeks intervention period.
Study NCT05426226 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laser acupuncture
Description: using laser acupuncture device on sleep acupoints during sleep
Study NCT05426226 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham device
Description: using sham device on sleep acupoints during sleep
Study NCT05432635 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-CD19-CAR CMV-specific T-lymphocytes
Description: Given IV
Study NCT05432635 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous Hematopoietic Stem Cell Transplantation
Description: Undergo autoHSCT
Study NCT05432635 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
Description: Given IM
Study NCT05641987 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Workplace Participatory Program
Description: The Center for the Promotion of Health in the New England Workplace's (CPH-NEW's) Healthy Workplace Participatory Program (HWPP) is a participatory process in which end-users design TWH interventions that simultaneously change organizational and individual behavior to improve the health, safety and well-being of their workforce. The HWPP uses a process to empower workers to identify the root causes of health and safety concerns and then design, implement and evaluate interventions to address those problems. The Total Teacher Health Project adapted the HWPP for educators and refer to it as the Educator Well-being Program.
Study NCT05641987 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Workplace Participatory Program
Description: The Center for the Promotion of Health in the New England Workplace's (CPH-NEW's) Healthy Workplace Participatory Program (HWPP) is a participatory process in which end-users design TWH interventions that simultaneously change organizational and individual behavior to improve the health, safety and well-being of their workforce. The HWPP uses a process to empower workers to identify the root causes of health and safety concerns and then design, implement and evaluate interventions to address those problems. The Total Teacher Health Project adapted the HWPP for educators and refer to it as the Educator Well-being Program.
Study NCT04573218 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo contains glucose
Study NCT04573218 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 250 mg OPP
Description: 250 mg Oil Palm Phenolics
Study NCT05086874 — intervention group
Intervention type: OTHER
Intervention: butylphthalide
Description: Observational only and no predesigned interventions in this study